FDA issues warning letter to two breast implant manufacturers
On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.